Of the DNA bases, peroxynitrite (ONOO ؊ ) is most reactive toward 2-deoxyguanosine (dGuo), but even more reactive with 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodGuo), requiring a 1,000-fold excess of dGuo to provide 50% protection against the reaction with 8-oxodGuo. Therefore, it seems reasonable that 8-oxodGuo is a potentially important target in DNA and that the structures of the reaction products with ONOO ؊ should be characterized. 
Of the DNA bases, peroxynitrite (ONOO ؊ ) is most reactive toward 2-deoxyguanosine (dGuo), but even more reactive with 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodGuo), requiring a 1,000-fold excess of dGuo to provide 50% protection against the reaction with 8-oxodGuo. Therefore, it seems reasonable that 8-oxodGuo is a potentially important target in DNA and that the structures of the reaction products with ONOO ؊ should be characterized. ⅐-) (1) and is a highly reactive molecule; it is stable in the anion form (pH ϭ 12) but decays rapidly with a half-life of 1 s at physiologic pH in a process that involves protonation to form peroxynitrous acid (ONOOH, pK a ϭ 6.8). It is proposed that the protonation of ONOO Ϫ results in a high-energy, reactive intermediate, ONOOH*, which can either decay to give nitrate or react with substrate (2, 3) . In the presence of bicarbonate, the peroxynitrosocarbonate anion, (ONOOCO 2 Ϫ ) is formed from ONOO Ϫ in a carbon dioxide catalyzed reaction (4) (5) (6) (7) . Although ONO-OCO 2 Ϫ has a shorter lifetime than ONOO Ϫ , the former is still a potent oxidizing agent, with a redox potential in excess of ϩ 1 V (4, 8) .
An important source of ONOO Ϫ in vivo is the activated macrophage. This cell type has been implicated in causing tissue damage during acute and chronic inflammatory conditions by mechanisms that might involve ONOO Ϫ (9). Indeed, 3-nitrotyrosine, a putative marker of ONOO Ϫ formation, has been detected in people with acute lung injury (10, 11) and rheumatoid arthritis (12) . In addition to reacting with lipids (13), proteins (14) , and cellular thiols (15) (16) (17) (18) (19) , ONOO Ϫ can cause DNA damage. The spectrum of DNA damage includes strand breakage (20) (21) (22) and both oxidation (22) and nitration (23) of bases.
Of the DNA nucleosides, 2Ј-deoxyguanosine (dGuo) is the most reactive toward ONOO Ϫ . Several reaction products are observed including the nitration product, 8-nitro-2Ј-deoxyguanosine (23); the addition product, 4,5-dihydro-5-hydroxy-4-(nitrosooxy)-2Ј-deoxyguanosine (24) ; and the oxidation products, 2,2-diamino-4-[(2-deoxy-␤-D-er ythro-pentofuranosyl)amino]-5-(2H)-oxazolone and 4-hydroxy-8-oxo-4,8-dihydro-2Ј-deoxyguanosine (25) . Furthermore, 8-oxodGuo is more reactive toward ONOO Ϫ than is dGuo, requiring a 1,000-fold excess of dGuo to provide 50% protection of 8-oxodGuo from reaction with ONOO Ϫ (26). 8-oxodGuo can be present in cellular DNA at levels in the range of 4 to 11 in 10 7 bases (27) . Further, given the preferential reactivity of this lesion toward ONOO Ϫ , we have hypothesized that knowledge of the structure of the lesions produced by reaction of 8-oxodGuo with ONOO Ϫ could be essential in understanding how ONOO Ϫ induces DNA damage and plays a role in mutagenesis.
Given the propensity for 8-oxodGuo to undergo further oxidation, we reasoned that this would be the most likely mode of reaction of 8-oxodGuo with ONOO Ϫ . There are several important models for the oxidation of 8-oxodGuo: (i) the alkaline potassium permanganate or iodine-mediated oxidation of uric acid; (ii) the electrochemical oxidation of 8-oxoGua; and (iii) the photooxidation of 8-oxodGuo. Alkaline oxidation of uric acid leads to the formation of allantoin and dehydroallantoin as major products (28) . Electrochemical oxidation of 8-oxoGua results in formation of 2,5-diaminoimidazol-4-one (IIa) and 5-guanidinohydantoin (29) . Photooxidation of 8-oxodGuo leads to the formation of 1,3,5-triazine-1(2H)-carboximidamide, 3-(2-deoxy-␤-D-erythro-pentofuranosyl)tetrahydro-2,4,6-trioxo-(I) as the major product. This compound then undergoes basemediated hydrolysis to yield 1-(2-deoxy-␤-D-erythro-pentofuranosyl)cyanuric acid (Ia) (30) .
Using these systems as models for the ONOO Ϫ -mediated oxidation of 8-oxodGuo, the major immediate products of this reaction have been identified.
Materials and Methods
Materials. Cyanuric acid, parabanic acid, potassium oxonate, and 2-amino-6,8-dihydroxypurine (8-oxoGua) were obtained from Aldrich (Milwaukee, WI). 8-Oxo-7,8-dihydro-2Ј-deoxyguanosine (8-oxodGuo) was either obtained from Sigma or synthesized as described by Kasai and Nishimura (31) . Potassium permanganate (Fisher Scientific), sodium borohydride (NaBH 4 ) (American Bioanalytical, Natick, MA), and acetic anhydride (Mallinckrodt) were analytical grade. Silylation grade pyridine was obtained from Pierce, and bis(trimethylsilyl)trif luoroacetamide was from Supelco. Peroxynitrite was synthesized by the ozonation of an aqueous alkaline solution of sodium azide (32) . All solvents were HPLC grade.
Instrumentation. UV/Vis measurements were made by using an HP8452 Diode Array Spectrophotometer (Hewlett-Packard). H-NMR spectra were recorded at 300 or 500 MHz and 13 C-NMR spectra (proton decoupled) at 75 or 125 MHz on Unity 300 and Inova 500 spectrometers, respectively. HPLC was performed by using an HP1090 pump equipped with a 1090 Diode Array Detector (Hewlett-Packard 3,5-Di-O-Ac-8-oxodGuo Synthesis and Purification. 3Ј,5Ј-Di-O-Ac-8-oxodGuo was prepared by heating a suspension of 8-oxodGuo (1 mg) in pyridine (100 l) and acetic anhydride (60 l) at 70°C for 30 min. Unreacted acetic anhydride was quenched by addition of methanol (250 l), and the mixture was dried in vacuo. The residue was dissolved in double-distilled water and purified by semipreparative HPLC on a 250 ϫ 10 mm, 7 m RP-300 column (Alltech Associates). Solvents A and B were 50 mM ammonium acetate, pH 5.5 and acetonitrile, respectively. Isocratic elution with 5% B for 5 min was followed by a gradient from 5% B to 22% B in 18 min. After holding at 22% B for 4 min, the column was ramped from 22% B to 5% B in 3 min. A flow rate of 2.5 ml/min was used, and products were monitored simultaneously at 225 nm and 260 nm. The desired 3Ј,5Ј-di-OAc-8-oxodGuo eluted at 19.8 min under these conditions. Fractions containing the desired product were collected, pooled, and lyophilized. Excess ammonium acetate was removed by taking up the residue in double-distilled water and lyophilizing several times. ( ϭ 302 nm, 0.1 M NaOH) (36), respectively. Reactions were performed by adding the desired amount of 3Ј,5Ј-di-O-Ac-8-oxodGuo to a buffered solution in an Eppendorf tube (1.5 ml). ONOO Ϫ was placed as a droplet on the underside of the lid. After carefully closing, the tube was vigorously vortexed for 1 min to effect complete reaction.
Separation of 3,5-Di-O-Ac-8-oxodGuo/ONOO -Reaction Products. After reacting 100 M 3Ј,5Ј-di-O-Ac-8-oxodGuo with 500 M ONOO Ϫ , products were separated by HPLC using a 250 ϫ 4.6 mm, 5 m LC-18-DB column (Supelco). The mobile phases used were 50 mM ammonium acetate and acetonitrile. HPLC conditions used were: isocratic 5% B for 10 min; 5% B to 27.4% B in 20 min; 27.4% B to 5% B in 5 min. The flow rate was 1 ml/min, and products were monitored simultaneously at 230 nm and 260 nm.
Reduction of Compound II. For analytical studies, a 100 M 3Ј,5Ј-di-O-Ac-8-oxodGuo solution was treated with 500 M ONOO Ϫ (final total volume ϭ 1 ml). Treating either the HPLC-purified product or the crude 3Ј,5Ј-di-O-Ac-8-oxodGuo/ ONOO Ϫ reaction mixture with NaBH 4 effected reduction of II. The fraction containing purified II (volume ϭ 350-400 l) or the crude reaction mixture (volume ϭ 1 ml) was treated with 5 l of an aqueous 1 M NaBH 4 stock solution. The mixtures were incubated at room temperature for 5-10 min and then analyzed by HPLC using the same conditions for purifying the 3Ј,5Ј-di-O-Ac-8-oxodGuo/ONOO Ϫ reaction products. Reduction of II was complete and yielded two products, II red ( max ϭ 229 nm, M r ϭ 357) and II red ( max ϭ 227 nm, M r ϭ 357), which had retention times of 18.1 and 18.9 min, respectively. In preparative studies, 0.084 mmol (30 mg) of 3Ј,5Ј-di-O-Ac-8-oxodGuo was treated with 0.50 mmol ONOO Ϫ in 150 mM KH 2 PO 4 , 25 mM Na 2 CO 3 , pH 7.2 (80 ml), and 0.80 mmol NaBH 4 added to reduce the products formed. The reaction mixture was concentrated by rotary evaporation and purified by semipreparative HPLC on a Nucleosil C18 250 ϫ 10 mm, 5 m column (Alltech Associates) with the same gradient and solvents used in the analytical studies and a flow rate ϭ 3.0 ml/min. Under these conditions, II red /II red eluted as a single peak. The product was desalted on a C18 Mega Bond Elut column (Varian), eluted with methanol and dried in vacuo. 1 and II isolated by analytical HPLC as described before, except that 60 mM KH 2 PO 4 , pH 7.4 was used as the aqueous mobile phase. Ten microliters of concentrated ammonium hydroxide was added to the fraction containing II (520 l), and the mixture was incubated at room temperature for 1.5 hr. This hydrolysis mixture was analyzed by HPLC using the same conditions used to isolate II. Hydrolysis of II yielded IIa ( max ϭ 249 nm and 313 nm; M r ϭ 112), IIb ( max ϭ 225 nm, shoulder 260-310 nm; M r ϭ 313), and IIc ( max ϭ 213 nm; M r ϭ 332), which eluted at 3.3, 26.2, and 21 min, respectively.
Preparation of 2,3,5-Tri-O-Ac-␤-D-erythro-Pentofuranosyl Derivative of IIc (IIc).
The starting material, 2Ј,3Ј,5Ј-tri-O-Ac-8-oxoGuo, was prepared according to the procedure by Ikehara et al. (37) , except that the 8-BrGuo was acetylated by using standard procedures (38) . IIc then was prepared by reacting 2Ј,3Ј,5Ј-tri-
O-
0.141 mmol, 1.68 ml). Reactions were initiated by forcefully pipetting the ONOO Ϫ into the vigorously stirred nucleoside solution. The product corresponding to II, (II), was purified by semipreparative HPLC on a Nucleosil C18 250 ϫ 10 mm, 5-m column (Alltech Associates) by using 10 mM KH 2 PO 4 , pH 7.4 (solvent A) and acetonitrile (solvent B) as mobile phases. HPLC elution conditions used were: isocratic, 5% B for 10 min; 5% to 40% B in 35 min; 40% to 5% B in 5 min. The flow rate was 3.5 ml/min, and products were monitored simultaneously at 225 nm and 260 nm. II eluted at 32 min. Fractions containing II were pooled, dried, and taken up in 1. The residue was taken up in double-distilled water (1 ml), and I, II, and III were purified by analytical HPLC using 50 mM ammonium acetate and acetonitrile as mobile phases. Isolated II was base-hydrolyzed to give IIa and IIb as described above. II red and II red were HPLC-purified from 10 separate reactions of 100 M 3Ј,5Ј-di-O-Ac-8-oxodGuo with 750 M ONOO Ϫ , with NaBH 4 (5 l of a 1 M stock) added to effect reduction of II. The HPLC fractions containing I, IIb, III, II red , and II red were dried in vacuo, and the residues were taken up in 6 M HCl (75 l), transferred to silinized reacti-vials (0.5 ml), and heated at 100°C for 5 min to remove the 3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl moiety. These solutions then were cooled to room temperature and dried in vacuo. IIa, which lacks the 3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl moiety, was not subjected to acid hydrolysis. Hence, the HPLC fraction containing IIa was dried in vacuo and subsequently derivatized as described below. Samples were derivatized for GC/MS analysis using a 1:1 mixture of bis(trimethylsilyl)trifluoro-acetamide in acetonitrile (100 l). The aglycons of IIb and III were derivatized by heating at 130°C for 10 min. The aglycons of I, IIa, II red , and II red were derivatized similarly, except that these samples were heated for 20 min. All samples were cooled to room temperature, and 5-10 l was used per GC/MS analysis.
Preparation of Authentic Standards for GC/MS.
One hundred micrograms each of 5-azauracil, cyanuric acid, (2-imino-5-oxoimidazolidin-4-yl)urea, and parabanic acid were transferred in aqueous solution to silinized reacti-vials. The solutions were dried in vacuo, and the residues were taken up in 100 l of a 1:1 bis(trimethylsilyl)trif luoro-acetamide/acetonitrile mixture. Heating the respective solutions at 130°C for 10 min effected derivatization of 5-azauracil and parabanic acid. Cyanuric acid and (2-imino-5-oxo-imidazolidin-4-yl)urea were derivatized similarly, except that these solutions were heated for 20 min. Derivatized samples were diluted 10-fold with hexane and 1-5 l was injected per analysis.
GC/MS Analyses. All analyses were performed by using a 12.5 m ϫ 0.22 mm ϫ 0.33 m film thickness HP-1 column (HewlettPackard). Either electron ionization or positive ion chemical ionization (PICI) was used. In PICI studies, methane was used as the bath gas. The injector and inlet temperatures were set at 250°C and the source temperature at 200°C. The quadrupole temperature was kept at 100°C. An electron ionization energy of 70 eV was used in all studies. Helium was used as the carrier gas, and the column head pressure was set at 6 psi. In all studies of the derivatized aglycons and authentic standards, the column temperature was ramped from 60°C at 0 min to 250°C at a rate of 20°C/min and then held constant at 250°C for 5 min. All injections were made in splitless mode.
Results and Discussion
The treatment of 3Ј,5Ј-di-O-Ac-8-oxodGuo with ONOO additional compounds. The first compound, I ( max ϭ 216 nm, M r ϭ 371), eluted at 23 min. The second compound, II ( max ϭ 236 nm; shoulder 275-350 nm; M r ϭ 355), eluted at 24.5 min, and the third compound, III ( max ϭ 220 nm and 280 nm; M r ϭ 314), eluted at 24.9 min. The fourth compound is not presently characterized and will not be discussed further. Over a range of ONOO Ϫ concentrations, II is the major product of the reaction of 3Ј,5Ј-di-O-Ac-8-oxodGuo with ONOO Ϫ whereas I and III are formed in lower but similar amounts. These three compounds have been studied in detail and structurally characterized.
Characterization of II.
Direct structural studies of II were impaired because of its inherent instability. However, HRMS revealed that the molecular formula for this compound is C 13 By characterizing the stable reduction products along with the hydrolysis products, it was possible to propose that the intermediate II is most likely 1-(3,5-di-O-Ac-2-deoxy-␤-D-erythropentofuranosyl)-3-(2-imino-5-oxo-imidazolidin-4-ylidene)urea (Fig. 1) .
Several lines of evidence support this conclusion. The reduction products II red and II red were acid-hydrolyzed to yield the aglycons, and the trimethylsilyl derivatives of the aglycons were prepared and analyzed by GC/MS. Both II red and II red released a single aglycon that had the same retention time and fragmentation pattern as that of authentic (2-imino-5-oxo-imidazolidin-4-yl)urea (Table 1 ). This finding suggested that II red and II red constituted a diastereomeric pair. The 1 H-NMR spectra of II red and II red were essentially identical, a finding consistent with these compounds being diastereomers. Additionally, ESI-MS/MS experiments revealed that these compounds fragmented identically, yielding a major fragment in both cases with m/z ϭ 113, which corresponds to the 5-amino-2-imino-imidazolidin-4-one portion of II red /II red (Fig. 2) . Taken together, these data indicate that II red /II red are diastereomers of 1- The hydrolysis products of II also were characterized to gain further insight into its structure. Ammonium hydroxide-mediated hydrolysis yielded three compounds, IIa, IIb, and IIc. IIa (M r ϭ 112) has UV maxima at 249 nm and 313 nm and an HPLC retention time of 3.3 min. The dramatically shortened retention time relative to all of the primary reaction products along with the molecular weight of IIa indicated that the 3,5-di-O-Ac-2-deoxy-␤-D-erythropentofuranosyl moiety, M r ϭ 201) was not attached to IIa. The UV The aglycons of the OONO Ϫ -reaction products of 3Ј,5Ј-di-O-Ac-8-oxodGuo are shown in bold type next to the authentic standard that gave an identical retention time and fragmentation pattern.
spectrum of IIa was found to be identical to that reported for 2-amino-5-[(2-deoxy-␤-D-erythro-pentofuranosyl)amino]-4H-imidazol-4-one (39) . Furthermore, the mass spectrum of IIa using GC/MS in electron ionization mode revealed ions at m/z ϭ 328, 313, 285, and 198, a spectrum identical to that reported for 2,5-diaminoimidazol-4-one (29) . Hence, IIa is identified as 2,5-diaminoimidazol-4-one.
The second hydrolysis product, IIb (M r ϭ 313), has max ϭ 225 nm and a shoulder from 260 to 310 nm and an HPLC retention time of 26.2 min. HRMS indicated that this compound has a molecular formula C 12 H 15 N 3 O 7 (calculated exact mass: 313.0910; found: 313.0908) and hence, a base fragment with molecular formula, ions at m/z ϭ 312 and 313, respectively. This result indicated that IIb has two exchangeable protons, because in addition to having one deuteron in the observed ion, another deuteron was lost to form the observed negative ion. These exchangeable protons must be present in the base fragment because the 3,5-di-O-Ac-2-deoxy-␤-D-erythropentofuranosyl moiety has no exchangeable protons. Therefore, IIb is identified as 3-(3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl)-5-iminoimidazolidine-2,4-dione. Further, as has been reported previously for substituted 5-iminoimidazolidine-2,4-dione compounds, strong acid or base treatment will cause ring expansion to yield s-triazine structures, including oxonic acid and 5-azauracil, by mechanisms that are not clearly understood (28) . Indeed, acid hydrolysis of IIb led to release of an aglycon that was identified as 5-azauracil based on an identical GC/MS retention time and fragmentation pattern as authentic 5-azauracil (Table 1) , thus further indirectly supporting the proposed structure for IIb.
Importantly, IIb is unstable and undergoes hydrolysis to yield IIc as a stable end product. IIc, as determined by negative ion ESI-MS, has a M r ϭ 332 and three exchangeable protons. To facilitate 1 H-NMR studies aimed at identifying the aglycon of IIc, the 2,3,5-tri-O-Ac-␤-D-erythro-pentofuranosyl analog (IIc), was used. IIc was used because it could be prepared from the parent compound, 2Ј,3Ј,5Ј-tri-O-Ac-8-oxoGuo, which is easily accessible synthetically and in high yield. We verified that IIc and IIc had identical UV/Vis spectra and that the molecular weight of IIc (M r ϭ 390) was the expected 58 atomic mass units greater than that of IIc (M r ϭ 332). Therefore, it is concluded that IIc is 3-(3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl)oxaluric acid. Indeed, if substitution were at the N1 position, both amide protons would be identical and no coupling between the 3-NH 2 and H1Ј would be expected.
Any structure proposed for II must account for the fact that reduction will yield the diastereomeric pair, II red and II red and the observed hydrolysis products, IIa, IIb, and IIc. As shown in Fig. 1 , reduction of II will directly yield the diastereomers II red and II red . Ammonium hydroxide-mediated ammonolysis or hydrolysis of II likely proceeds via nucleophilic attack at C4. Ammonolysis with elimination of (3,5-di-O-Ac-2-deoxy-␤-Derythro-pentofuranosyl)urea leads to formation of IIa. Alternatively, ring closure to yield intermediate II* followed by elimination of guanidine yields IIb (Fig. 1) , which ultimately hydrolyses to IIc.
Characterization of I and III. I and III were acid-hydrolyzed to obtain the aglycons. The trimethylsilyl derivative of the released aglycons was prepared and analyzed by GC/MS. The derivatized aglycons from I and III were found to have retention times and fragmentation patterns identical to those of authentic cyanuric acid and parabanic acid, respectively ( Table 1 ). The molecular weight calculated for the 1-(3,5-di-O-Ac-2-deoxy-␤-D-erythropentofuranosyl)parabanic acid matched that observed by ESI-MS. Further, the UV spectrum of III ( max ϭ 220 nm and 280 nm) matched that of the authentic parabanic acid. Therefore, III was identified as 1-(3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl)parabanic acid. This compound also is formed as a hydrolysis product of II upon incubation in 150 mM KH 2 PO 4 , pH 7.4 buffer (Fig. 1 ) and also will yield IIc under the same conditions (Fig. 3) . All three products are hydrolytically labile. In 150 mM KH 2 PO 4 , 25 mM Na 2 CO 3 , pH 7.2 and at ambient temperature, II has a half-life of 5 hr. This compound is therefore relatively more labile than I whose half-life previously was determined to be days (30) . However, IIc is quite stable and little degradation occurs even after days of incubation at room temperature in pH 7.2 buffer. We have shown that I can arise from the further reaction of II with ONOO Ϫ . At present, however, it is not possible to definitively say whether III arises solely as a hydrolysis product of II or whether it is also a direct product of the reaction of 3Ј,5Ј-di-O-Ac-8-oxodGuo with ONOO Ϫ .
The instability of II has impaired our efforts to rigorously characterize this compound. However, the reduction products, in particular, are highly informative about its structure. Reduction leads to formation of the diastereomers, II red and II red , which is most consistent with the assignment of II as 1-(3,5-di-O-Ac-2-deoxy-␤-D-erythro-pentofuranosyl)-3-(2-imino-5-oxo-imidazolidin-4-ylidene)urea. Presently, we cannot completely exclude the possibility that II is the ring-closed structure, 3-(3,5-di-O-Ac-2-deoxy-␤-D-er ythro-pentofuranosyl)-3a-hydroxy-5-imino-3,3a,4,5-tetrahydro-1H-imidazo [4,5-d] imidazol-2-one. The bicyclic and the ring-opened structures are not mutually exclusive possibilities, however, as the former structure is highly strained and may be in equilibrium with the ring-opened structure.
In conclusion, we have identified the major immediate and hydrolysis products of the reaction of 3Ј,5Ј-di-O-Ac-8-oxodGuo with ONOO Ϫ . Under our experimental conditions, II is the major product at the low ONOO Ϫ treatment levels. This is important when considering the reaction of 8-oxoGua lesions in DNA with ONOO Ϫ . Our experiments indicate that these lesions also are formed in oligonucleotides containing an 8-oxoGua residue (40) . Understanding the impact of the reaction of 8-oxoGua in DNA with ONOO Ϫ will require studying specifically the formation and fate of II in DNA. The half-life of II at physiologic pH (5 hr) indicates that within 2 days of formation, it is completely hydrolyzed to its stable hydrolysis product, IIc. Lesions bearing remarkable structural resemblance to IIc, for example the glycoside of ␤-ureidoisobutyric acid, have been shown to be premutagenic and to function as potent blocks to DNA replication (41) .
